L’Oréal is Set to Acquire British Brand Medik8

The British business newspaper Financial Times has just announced that L'Oréal is about to acquire the British brand Medik8. The large-scale financial transaction is said to be worth €1 billion and is part of a broader series of acquisitions and partnerships.

Following the acquisition of Australian company Aesop in 2023, the cosmetics giant would thus take over this innovative British brand, which specializes in skincare and is renowned for its high-end formulations and research-based approach.

This acquisition is strategic for a number of reasons: Medik8 has a strong reputation in the anti-aging segment, a rapidly growing area, particularly in Asia, where consumers favor targeted and effective solutions. Founded in 2009 by Elliott Isaac, an expert in pharmacology and biochemistry, Medik8 continues to grow. With the opening of a new research center in the United States, it has become a key player in the field of “dermatological beauty.”

This sector is a particular focus for L'Oréal, which already has highly popular brands such as Vichy and La Roche Posay in its portfolio and has signed partnerships with major research centers such as the Swiss laboratory Galderma.

Inflexion, a major European private equity firm that invests in high-growth companies, is currently the main shareholder in the British cosmetics brand that L'Oréal has its sights set on.
The French group has not yet commented on the news, but according to the City daily, the deal is expected to be announced in the coming days.

For L'Oréal, the dermatological beauty sector continued to grow throughout the first quarter of this year, posting a 3.5% increase and sales of €2.1 billion.

With an increasingly rich portfolio that meets the diverse needs of consumers, the French giant, currently valued at €205 billion, is continuing its expansion. It is increasingly targeting promising markets outside Europe, starting with India, where the group intends to double its business, as explained by CEO Nicolas Hieronimus during the recent European tour of Indian Minister of Commerce Piyush Goyal.